Citic Private Equity Said to Consider Biosensors Acquisition

Lock
This article is for subscribers only.

Citic Private Equity Funds Management Co. is considering buying full control of medical devices maker Biosensors International Group Ltd., said two people with knowledge of the deliberations.

The Beijing-based firm, an arm of China’s state-backed Citic Group Corp. conglomerate, is in talks with several banks about financing for a deal, said the people, who asked not to be identified because the information is private. It owns about 22 percent of the Singapore-listed company, which had a market value of S$1.5 billion ($1.2 billion) as of yesterday. Biosensors shares were suspended after surging today.